chronic idiopathic urticaria chronic idiopathic urticaria
Conditions
Interventions
None listed
Sponsors
Fujimoto Manabu
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals who meet the diagnostic criteria for chronic idiopathic urticaria as outlined in the 2018 Urticaria Treatment Guidelines. Specifically, individuals who have experienced itchy red patches that appear and disappear within 24 hours for a period of six weeks or longer. 2. Individuals who are 18 years of age or older at the time of consent. 3. Individuals who have provided written consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding women 2. Individuals with atopic dermatitis 3. Individuals who have used omalizumab, an anti-IgE monoclonal antibody, within the past 3 months 4. Other individuals deemed ineligible by the principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No evaluation items for basic research. The correlation between the following clinical information and clinical sample analysis results will be examined. 1. Basic information: age, gender, how long you have had the disease, Urticaria Activity Score 2. What you have already had: atopic dermatitis, bronchial asthma, allergic rhinitis, angioedema, autoimmune diseases 3. Medications you are taking: antihistamines, antiallergic drugs, steroids, immunosuppressants, biologics 4, Blood values: white blood cell count, leukocyte formula, immunoglobulin, anti-TPO IgG antibodies, antinuclear antibodies | — |
Contacts
Public ContactYutaka Matsumura
The University of Osaka Hospital
Outcome results
None listed